Blueprint Medicines shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Blueprint Medicines
Tip: Access up to 7 years of quarterly data
All positions including Blueprint Medicines held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Blueprint Medicines by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $80M | 739k | 107.78 |
| 2024-03-31 | $54M | 567k | 94.86 |
| 2023-12-31 | $54M | 589k | 92.24 |
| 2023-09-30 | $18M | 356k | 50.22 |
| 2023-06-30 | $25M | 400k | 63.20 |
| 2023-03-31 | $16M | 345k | 44.99 |
| 2022-12-31 | $14M | 317k | 43.81 |
| 2022-06-30 | $13M | 258k | 50.51 |
| 2022-03-31 | $20M | 307k | 63.88 |
| 2021-12-31 | $43M | 401k | 107.11 |
| 2021-09-30 | $63M | 613k | 102.81 |
| 2021-03-31 | $48M | 488k | 97.23 |
| 2020-12-31 | $64M | 570k | 112.15 |
| 2020-09-30 | $48M | 515k | 92.70 |
| 2020-06-30 | $44M | 564k | 78.00 |
| 2019-12-31 | $31M | 385k | 80.11 |
| 2019-09-30 | $27M | 366k | 73.47 |
| 2019-06-30 | $33M | 352k | 94.33 |
| 2019-03-31 | $32M | 402k | 80.05 |
| 2018-12-31 | $21M | 380k | 53.91 |
| 2018-09-30 | $33M | 420k | 78.06 |
| 2018-06-30 | $23M | 355k | 63.48 |
| 2018-03-31 | $28M | 304k | 91.70 |
| 2017-12-31 | $15M | 194k | 75.41 |
| 2017-09-30 | $16M | 226k | 69.67 |
| 2017-06-30 | $13M | 261k | 50.67 |
| 2017-03-31 | $14M | 354k | 39.99 |
| 2016-12-31 | $2.6M | 93k | 28.05 |
| 2016-09-30 | $939k | 32k | 29.69 |
| 2016-03-31 | $6.3M | 347k | 18.06 |
| 2015-12-31 | $10M | 394k | 26.34 |
| 2015-09-30 | $205k | 9.6k | 21.31 |
| 2015-06-30 | $500k | 19k | 26.50 |